<DOC>
	<DOCNO>NCT02323360</DOCNO>
	<brief_summary>The trial multicentre , prospective , randomise control , unblinded , parallel-group superiority trial SBRT versus standard TAE/TACE curative treatment inoperable HCC treat TAE/TACE incomplete cycle .</brief_summary>
	<brief_title>A Trial SBRT After Incomplete TAE TACE Versus Exclusive TAE TACE For Treatment Inoperable HCC</brief_title>
	<detailed_description>In phase III study patient inoperable HCC single nodule 5 cm 1- 3 nodule 3 cm diameter incomplete TAE TACE , randomize stereotactic radiotherapy 3 6 daily fraction new cycle TAE TACE . A total 80 patient ( 40 arm ) recruit trial 2 year period randomise equal basis either SBRT TAE/TACE . The follow-up period finish 1.5 year final patient randomise .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Chlorotrianisene</mesh_term>
	<criteria>Age &gt; 18 year Karnofsky index &gt; 70 % ChildTurgottePugh A B liver score . An initial diagnosis primary HCC recurrence . A technically unresectable lesion medically contraindicate surgery case surgery decline . HCC ( single nodule ≤ 5 cm max 3 nodule ≤ 3 cm ) diagnose histology noninvasive EASL criterion Baseline CT MRI bone scan without evidence radiologically definable major vascular invasion extrahepatic disease Hb &gt; 10.5.0 g/ % , WBC &gt; 3.000 cells/mm3 , platelet &gt; 50.000 cells/mm3 , bilirubin &lt; 2 mg/dl , aspartate alanine aminotransferase level &lt; 5 time upper normal limit , prothrombin timeinternational normalize ratio ≤ 2 ; Serum creatinine &lt; 1.7 mg/dl Previously incomplete TAE TACE radiologically define residual disease . Informed consent Extrahepatic disease refractory ascites . Previous abdominal radiation therapy ( RT ) Hemorrhage/bleeding event = Grade 3 within 4 week enrollment study . Pregnant breastfeeding patient . Patients uncontrolled infection HIV seropositive patient . Mental condition render patient incapable understand nature , scope , consequence study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>SBRT</keyword>
	<keyword>TACE</keyword>
	<keyword>TAE</keyword>
</DOC>